$PLX Headlines In focus: Awaiting the next move 8:57

New Post Public Reply Private Reply Replies (0) Message Board

Oct 13, 2014 at 1:50 PM

$PLX Headlines

In focus: Awaiting the next move 8:57 p.m. Feb. 6, 2013 - Lawrence G. McMillan
Using Plants to Make Cheaper Biotech Drugs 10:41 a.m. July 9, 2012 - MarketWatch
Wells Fargo cuts Protalix to market perform 9:11 a.m. June 25, 2012 - Greg Morcroft
Friday’s biggest gaining and declining stocks 4:33 p.m. June 22, 2012 - MarketWatch
Wednesday’s biggest gaining and declining stocks 4:47 p.m. May 2, 2012 - MarketWatch
Protalix, Formfactor, Opentable see options volume surge 12:20 p.m. May 2, 2012 - blogs.marketwatch.com
Canaccord cuts Protalix to hold from buy 9:17 a.m. May 2, 2012 - Greg Morcroft
Genworth rises, Chesapeake falls after hours 5:24 p.m. May 1, 2012 - Myra P. Saefong
American Capital options volume surges 10:48 a.m. May 1, 2012 - blogs.marketwatch.com
Protalix prices shares at 14% discount 11:51 a.m. Feb. 16, 2012 - MarketWatch.com
Tuesday’s biggest gaining & declining stocks 5:48 p.m. Dec. 6, 2011 - Kate Gibson
Protalix shares riae 4.6% in preopen trade 8:58 a.m. Aug. 17, 2011 - Greg Morcroft
FDA accepts Protalix resubmission for Gaucher drug 8:57 a.m. Aug. 17, 2011 - MarketWatch.com
Israel stocks lower; Ness agrees to takeover 8:56 a.m. June 12, 2011 - Robert Daniel
Israel stocks fall after central bank’s rate hike 9:12 a.m. May 24, 2011 - Robert Daniel
Israel stocks edge higher, lifted by energy sector 11:12 a.m. May 19, 2011 - Robert Daniel
Israel stocks advance, led by finance, property 7:32 a.m. March 21, 2011 - Robert Daniel
Israel up as Strauss, Migdal, Gazit-Globe report 9:20 a.m. March 16, 2011 - Robert Daniel
Israel stocks lower; Prolor and Protalix ease 8:51 a.m. March 6, 2011 - Robert Daniel
Medicis, PDL lead drug stocks north 12:47 p.m. Feb. 28, 2011 - Val Brickates Kennedy

Ebola traders need to rest 10:52 a.m. Today - Seeking Alpha
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 8:12 a.m. Oct. 3, 2014 - Seeking Alpha
How Protalix BioTherapeutics (PLX) Stock Stands Out in a Strong Industry - Tale of the Tape 8:42 a.m. Sept. 26, 2014 - Zacks.com
Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Russia Units - Analyst Blog 3:12 p.m. Sept. 5, 2014 - Zacks.com
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog 5:00 p.m. Aug. 29, 2014 - Zacks.com
Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape 9:11 a.m. Aug. 29, 2014 - Zacks.com
InsiderInsights.com Daily Round Up: 8/15/14 3:06 a.m. Aug. 17, 2014 - Seeking Alpha
Facebook Leads 3 High-Volume Young Gun Stock Leaders 6:14 p.m. June 24, 2014 - Investors Business Daily
Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog 6:15 p.m. June 19, 2014 - Zacks.com
Protalix (PLX) in Focus: Stock Adds 6.5% in Session - Tale of the Tape 9:25 a.m. June 19, 2014 - Zacks.com
Protalix commences Phase 2a Gaucher trial 9:01 a.m. June 18, 2014 - Seeking Alpha
Protalix chief to retire 9:25 a.m. June 13, 2014 - Seeking Alpha
Elelyso gets the nod in Canada 7:52 a.m. May 30, 2014 - Seeking Alpha
10-Q: PROTALIX BIOTHERAPEUTICS, INC. 4:36 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Relative Strength Alert For Protalix BioTherapeutics 12:22 p.m. April 25, 2014 - TheStreet.com
Protalix Biotherapeutics - A Compelling Buy Due To Validation Of Oral Protein Delivery Technology 12:33 p.m. Feb. 13, 2014 - Seeking Alpha
24/7 suggests eight biotech trading near $5 with big upside potential 9:25 a.m. Feb. 8, 2014 - Seeking Alpha
Protalix provides 2014 outlook, shares rise 10:07 a.m. Jan. 13, 2014 - Seeking Alpha
6 Biotechnology Stocks to Sell Now 6:30 a.m. Jan. 8, 2014 - InvestorPlace.com
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More 8:47 a.m. Jan. 7, 2014 - 247WallSt.com

Protalix BioTherapeutics Appoints Moshe Manor as President and Chief Executive Officer 2:00 a.m. Sept. 29, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 7:37 a.m. Sept. 4, 2014 - GlobeNewswire
Protalix Announces Conference Call to Discuss ELELYSO Pediatric Approval and Provide Updates on Additional Programs 5:52 p.m. Aug. 28, 2014 - GlobeNewswire
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease 1:15 p.m. Aug. 28, 2014 - BusinessWire - BZX
Protalix BioTherapeutics Names Shlomo Yanai as Chairman of the Board of Directors 8:01 a.m. July 24, 2014 - GlobeNewswire
Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa) Presented at the European Working Group on Gaucher Disease 2014 11th Meeting 7:01 a.m. June 27, 2014 - GlobeNewswire
Protalix BioTherapeutics Initiates Phase II Study With PRX-112, an Orally-Administered Enzyme Replacement Therapy for the Treatment of Gaucher Disease 7:31 a.m. June 18, 2014 - GlobeNewswire
Protalix BioTherapeutics' President and Chief Executive Officer, David Aviezer, Ph.D., Will Retire This Year 8:01 a.m. June 13, 2014 - GlobeNewswire
Protalix Announces ELELYSO(TM) (taliglucerase alfa) Approved in Canada for the Treatment of Gaucher Disease in Both Adult and Pediatric Patients 7:31 a.m. May 30, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences 7:32 a.m. May 28, 2014 - GlobeNewswire
Protalix Announces ELELYSO(TM) (taliglucerase alfa) Approved in Australia for the Treatment of Gaucher Disease in Both Adult and Pediatric Patients 7:32 a.m. May 22, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at the Oppenheimer 15th Annual Israeli Conference and the MIXiii Israel Innovation Conference, Biomed 7:31 a.m. May 7, 2014 - GlobeNewswire
Protalix Announces Data on Oral antiTNF to be Presented at Digestive Disease Week 2014 Meeting 8:32 a.m. April 23, 2014 - GlobeNewswire
Protalix BioTherapeutics Announces Oral GCD Data to be Presented at WORLD Symposium 2014 8:30 a.m. Feb. 12, 2014 - GlobeNewswire
Protalix BioTherapeutics' Technology Transfer Agreement for UPLYSO(TM) (alfataliglicerase) With Brazil's Ministry of Health Approved by the Brazilian National Institute of Industrial Property 8:30 a.m. Feb. 6, 2014 - GlobeNewswire
Protalix Announces Successful Manufacturing Facility Evaluation by Health Canada 5:30 p.m. Jan. 23, 2014 - GlobeNewswire
Protalix BioTherapeutics Provides Full-Year 2014 Strategic Outlook 8:30 a.m. Jan. 13, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference 8:30 a.m. Jan. 7, 2014 - GlobeNewswire
Protalix BioTherapeutics to Present at Oppenheimer's 24th Annual Healthcare Conference 10:00 a.m. Dec. 3, 2013 - GlobeNewswire
Protalix BioTherapeutics to Present at Upcoming Scientific and Medical Meetings 10:10 a.m. Oct. 31, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

eGlint's Rapid Tech Revolutionizes Proteomics with Win

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Plata Hits $1 Billion ARR in Record Digital Bank Growth

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Ruth E. Carter Returns Home with Celebrated Exhibition

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Navigating the Nitty-Gritty of Cabin Rental Management

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

2GenPen & LordCap Team Up: Game-Changer in ABS?

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

LBT Unveils Game-Changing Cyclotron for Medical Advances

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

CMS Proposal Sparks Controversy in Lab Certification

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

Noé Hinojosa Jr. Honored for Leadership in Business

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Clean Power Alliance's Bond Deal Secures $91M Savings

CPA Triumphs Yet Again With Bond Savings I'll tell you, the Clean Power Alliance (CPA) just hit the jackpot again. We're talking a $1.4 billion energy prepayment bond deal that locks in a whopping $91.1 million in savings over the next seven years. Not bad, huh? A Closer Look at the Numbers CPA's charm—besides being the top green power supplier in the U.S.—is spinning...